Peili Bu

Dr. Peili Bu


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 November 2016 in Oncotarget
Verified
Journal Article
Open access
PDF file
JLJingyuan Li
Jingyuan Li
TCTongshuai Chen
Tongshuai Chen
MXMing Xiao
Ming Xiao
NLNa Li
Na Li
SWShujian Wang
Shujian Wang
PBPeili Bu
Peili Bu
Mouse Sirt3 promotes autophagy in AngII-induced myocardial hypertrophy through the deacetylation of FoxO1 Mouse Sirt3 promotes autophagy in AngII-induced myocardial hypertrophy through the deacetylation of FoxO1

1 April 2022 in Frontiers in Pharmacology
Verified
Journal Article
Open access
YQYan Qi
Yan Qi
WLWenzhao Liu
Wenzhao Liu
XYXuefang Yan
Xuefang Yan
CZChen Zhang
Chen Zhang
CZChunmei Zhang
Chunmei Zhang
PBPeili Bu
Peili Bu
Intestinal flora plays an important role in atherosclerosis. Tongxinluo, as a multi-target Chinese medicine to improve atherosclerosis, whether it can improve atherosclerosis by affecting the intestinal flora is worth exploring. We established a vulnerable plaque model of atherosclerosis in New Zealand white rabbits by high cholesterol diet and balloon injury (HCB), and performed Tongxinluo intervention. We detected the level of inflammation by immunohistochemistry, Western Blot, and ELISA, analyzed plaque characteristics by calculating the vulnerability index, and analyzed the changes of gut microbiota and metabolites by 16S rRNA gene sequencing and untargeted metabolomic sequencing. The results showed that Tongxinluo intervention improved plaque stability, reduced inflammatory response, inhibited NLRP3 inflammatory pathway, increased the relative abundance of beneficial bacteria such as Alistipes which reduced by HCB, and increased the content of beneficial metabolites such as trans-ferulic acid in feces. Through correlation analysis, we found that some metabolites were significantly correlated with some bacteria and some inflammatory factors. In particular, the metabolite trans-ferulic acid was also significantly positively correlated with plaque stability. Our further studies showed that trans-ferulic acid could also inhibit the NLRP3 inflammatory pathway. In conclusion, Tongxinluo can improve plaque stability and reduce inflammation in atherosclerotic rabbits, which may be achieved by modulating intestinal flora and intestinal metabolism. Our study provides new views for the role of Tongxinluo in improving atherosclerotic vulnerable plaque, which has important clinical significance.

17 April 2017 in Oncotarget
Verified
Journal Article
Open access
PDF file
NLNa Li
Na Li
JZJie Zhang
Jie Zhang
XYXuefang Yan
Xuefang Yan
CZChen Zhang
Chen Zhang
HLHui Liu
Hui Liu
PBPeili Bu
Peili Bu
SIRT3-KLF15 signaling ameliorates kidney injury induced by hypertension

1 January 2021 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
CZChunmei Zhang
Chunmei Zhang
MSMengying Suo
Mengying Suo
LLLingxin Liu
Lingxin Liu
YQYan Qi
Yan Qi
CZChen Zhang
Chen Zhang
PBPeili Bu
Peili Bu
Oxidative stress and apoptosis play a vital role in the pathogenesis of contrast‐induced acute kidney injury (CI‐AKI). The purpose of our study was to investigate the protective effects and mechanisms of melatonin against CI‐AKI in a CI‐AKI mouse model and NRK‐52E cells. We established the CI‐AKI model in mice, and the animals were pretreated with melatonin (20 mg/kg). Our results demonstrated that melatonin treatment exerted a renoprotective effect by decreasing the level of serum creatinine (SCr) and blood urea nitrogen (BUN), lessening the histological changes of renal tubular injuries, and reducing the expression of neutrophil gelatinase‐associated lipid (NGAL), a marker of kidney injury. We also found that pretreatment with melatonin remarkably increased the expression of Sirt3 and decreased the ac‐SOD2 K68 level. Consequently, melatonin treatment significantly decreased the oxidative stress by reducing the Nox4, ROS, and malondialdehyde (MDA) content and by increasing the superoxide dismutase (SOD) and glutathione peroxidase (GSH‐Px) activity levels. The antiapoptotic effect of melatonin on CI‐AKI was revealed by decreasing the ratio of Bax/Bcl2 and the cleaved caspase3 level and by reducing the number of apoptosis‐positive tubular cells. In addition, melatonin treatment remarkably reduced the inflammatory cytokines of interleukin‐1β (IL‐1β), tumor necrosis factor α (TNFα), and transforming growth factor β (TGFβ) in vivo and in vitro. Sirt3 deletion and specific Sirt3 siRNA abolished the above renoprotective effects of melatonin in mice with iohexol‐induced acute kidney injury and in NRK‐52E cells. Thus, our results demonstrated that melatonin exhibited the renoprotective effects of antioxidative stress, antiapoptosis, and anti‐inflammation by the activation of Sirt3 in the CI‐AKI model in vivo and in vitro. Melatonin may be a potential drug to ameliorate CI‐AKI in clinical practice.

1 January 2021 in Life Sciences
Verified
Journal Article
Closed access
TCTongshuai Chen
Tongshuai Chen
CMChang Ma
Chang Ma
GFGuanqi Fan
Guanqi Fan
HLHui Liu
Hui Liu
XLXie Lin
Xie Lin
PBPeili Bu
Peili Bu

2 September 2021 in Frontiers in Pharmacology
Verified
Journal Article
Open access
JLJing Liu
Jing Liu
XZXuehui Zheng
Xuehui Zheng
CZChen Zhang
Chen Zhang
CZChunmei Zhang
Chunmei Zhang
PBPeili Bu
Peili Bu
Background: Lcz696 (ARNI, angiotensin receptor–neprilysin inhibitor; sacubitril/valsartan) shows an inhibitory effect on fibrosis after myocardial infarction (MI). However, the underlying signaling mechanisms are poorly understood. The Wnt/β-catenin signaling pathway is activated after MI and participates in the process of myocardial fibrosis. Here, we aimed to assess the efficacy of ARNI for alleviating myocardial fibrosis after MI and hypothesized that ARNI alleviates myocardial fibrosis by inhibiting the Wnt/β-catenin signaling pathway and overexpressing sFRP-1, an inhibitor of the Wnt/β-catenin signaling pathway.Methods: Mice randomized at 1 week post-MI were administered lcz696 (60 mg/kg, n = 21), valsartan (30 mg/kg, n = 19), or corn oil (n = 13) orally for 4 weeks, while the sham-operated group received vehicle (corn oil, n = 19). Cardiac function and extent of myocardial fibrosis were measured. Western blotting and quantitative real-time polymerase chain reaction were used to detect the expression of Wnt/β-catenin pathway-related proteins. Furthermore, primary myocardial fibroblasts were stimulated with angiotensin II (Ang II) and cultured with lcz696 and the sFRP-1 inhibitor way316606 to detect the expression of Wnt/β-catenin pathway proteins.Results: Both lcz696 and valsartan alleviated myocardial fibrosis and improved cardiac function, but lcz696 had superior efficiency compared to valsartan. Furthermore, β-catenin expression was inhibited and sFRP-1 was overexpressed after drug treatment, which could be significantly improved by lcz696 in mice. In addition, lcz696 inhibited β-catenin expression in AngII-stimulated myocardial fibroblasts, and β-catenin expression increased after the inhibition of sFRP-1.Conclusion: ARNI alleviated cardiac fibrosis and cardiac remodeling by inhibiting the Wnt/β-catenin signaling pathway. In addition, ARNI can lead to overexpression of sFRP-1, which is an inhibitor of the Wnt/β-catenin signaling pathway. These results indicate a new therapeutic target of ARNI to improve myocardial fibrosis and prevent myocardial remodeling.